Position in ABBV
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$27,368,618
+$3,680,478 QoQ
Shares Held
108,761
-0.1% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
3.00%
of 13F equity value
Holder Rank
#514
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PDS Planning, Inc holds $51,175,189 across 14 Drug Manufacturers - General names. ABBV ranks #1 (53.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
108,761 | $27,368,618 | |
| 2 | LLY |
ELI LILLY & Co
|
7,599 | $9,114,469 | |
| 3 | JNJ |
Johnson & Johnson
|
19,261 | $4,891,716 | |
| 4 | MRK |
Merck & Co., Inc.
|
17,830 | $2,291,155 | |
| 5 | NVS |
Novartis AG
|
9,632 | $1,509,527 | |
| 6 | AZN |
Astrazeneca PLC
|
6,926 | $1,313,308 | |
| 7 | AMGN |
Amgen Inc
|
3,399 | $1,230,845 | |
| 8 | PFE |
Pfizer Inc
|
31,747 | $764,467 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $27,368,618 | 108,761 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $23,688,140 | 108,916 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $25,255,685 | 110,533 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $25,004,467 | 107,992 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $20,029,140 | 107,904 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $22,515,438 | 107,462 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $19,031,847 | 107,101 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $21,426,974 | 108,502 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $17,817,326 | 103,879 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $18,860,279 | 103,571 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $16,045,128 | 103,537 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $15,382,246 | 103,195 | Shares | Sole | 2023-10-23 | |
| 2023-06-30 | $14,914,476 | 110,699 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | $19,696,378 | 123,589 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $19,755,691 | 122,243 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $16,495,751 | 122,910 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $18,911,124 | 123,473 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $19,737,216 | 121,752 | Shares | Sole | 2022-04-18 | |
| 2021-12-31 | $15,049,980 | 111,152 | Shares | Sole | 2022-01-25 | |
| 2021-09-30 | $8,907,904 | 82,580 | Shares | Sole | 2021-10-22 | |
| 2021-06-30 | $9,312,737 | 82,677 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $8,897,090 | 82,213 | Shares | Sole | 2021-04-20 | |
| 2020-12-31 | $8,809,873 | 82,220 | Shares | Sole | 2021-01-21 | |
| 2020-09-30 | $7,150,059 | 81,631 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $8,009,426 | 81,579 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $6,182,361 | 81,144 | Shares | Sole | 2020-04-20 | |
| No filing history on record for this holder in this stock. | ||||||